These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Gain-of-Function Zhang H; Schaefer A; Wang Y; Hodge RG; Blake DR; Diehl JN; Papageorge AG; Stachler MD; Liao J; Zhou J; Wu Z; Akarca FG; de Klerk LK; Derks S; Pierobon M; Hoadley KA; Wang TC; Church G; Wong KK; Petricoin EF; Cox AD; Lowy DR; Der CJ; Bass AJ Cancer Discov; 2020 Feb; 10(2):288-305. PubMed ID: 31771969 [TBL] [Abstract][Full Text] [Related]
4. c-Met-dependent phosphorylation of RhoA plays a key role in gastric cancer tumorigenesis. Liu J; Li S; Chen S; Chen S; Geng Q; Xu D J Pathol; 2019 Sep; 249(1):126-136. PubMed ID: 31056743 [TBL] [Abstract][Full Text] [Related]
5. In vivo effects of mutant RHOA on tumor formation in an orthotopic inoculation model. Nishizawa T; Nakano K; Fujii E; Komura D; Kuroiwa Y; Ishimaru C; Monnai M; Aburatani H; Ishikawa S; Suzuki M Oncol Rep; 2019 Nov; 42(5):1745-1754. PubMed ID: 31485674 [TBL] [Abstract][Full Text] [Related]
6. RAS and RHO family GTPase mutations in cancer: twin sons of different mothers? Hodge RG; Schaefer A; Howard SV; Der CJ Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):386-407. PubMed ID: 32838579 [TBL] [Abstract][Full Text] [Related]
7. A New Rho(d) Map to Diffuse Gastric Cancer. Benton D; Chernoff J Cancer Discov; 2020 Feb; 10(2):182-184. PubMed ID: 32024682 [TBL] [Abstract][Full Text] [Related]
8. RHOA mutation in diffuse-type gastric cancer: a comparative clinicopathology analysis of 87 cases. Ushiku T; Ishikawa S; Kakiuchi M; Tanaka A; Katoh H; Aburatani H; Lauwers GY; Fukayama M Gastric Cancer; 2016 Apr; 19(2):403-411. PubMed ID: 25823974 [TBL] [Abstract][Full Text] [Related]
9. RhoA G17E/Vav1 Signaling Induces Cancer Invasion via Matrix Metalloproteinase-9 in Gastric Cancer. Nakamura S; Kitazawa M; Miyagawa Y; Koyama M; Miyazaki S; Hondo N; Muranaka F; Tokumaru S; Yamamoto Y; Ehara T; Matsumura T; Takeoka M; Soejima Y Technol Cancer Res Treat; 2023; 22():15330338221146024. PubMed ID: 36617975 [TBL] [Abstract][Full Text] [Related]
10. RhoA mutations identified in diffuse gastric cancer. Zhou J; Hayakawa Y; Wang TC; Bass AJ Cancer Cell; 2014 Jul; 26(1):9-11. PubMed ID: 25026207 [TBL] [Abstract][Full Text] [Related]
11. RHOA takes the RHOad less traveled to cancer. Schaefer A; Der CJ Trends Cancer; 2022 Aug; 8(8):655-669. PubMed ID: 35568648 [TBL] [Abstract][Full Text] [Related]
12. Identification of "regulation of RhoA activity panel" as a prognostic and predictive biomarker for gastric cancer. Huang W; Zhao S; Zhang C; Li Z; Ge S; Lian B; Feng H; Wang K; Xu R; Ji J; Gao J; Shi W; Shen L Aging (Albany NY); 2020 Dec; 13(1):714-734. PubMed ID: 33288739 [TBL] [Abstract][Full Text] [Related]
13. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers. Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256 [TBL] [Abstract][Full Text] [Related]
14. Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer. Chang HR; Nam S; Lee J; Kim JH; Jung HR; Park HS; Park S; Ahn YZ; Huh I; Balch C; Ku JL; Powis G; Park T; Jeong JH; Kim YH Oncotarget; 2016 Dec; 7(49):81435-81451. PubMed ID: 27806312 [TBL] [Abstract][Full Text] [Related]
15. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway. Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells. Xu XT; Song QB; Yao Y; Ruan P; Tao ZZ Hepatogastroenterology; 2012; 59(120):2523-6. PubMed ID: 22584506 [TBL] [Abstract][Full Text] [Related]
18. Current Study of RhoA and Associated Signaling Pathways in Gastric Cancer. Liu H; Liu Y; Zhang X; Wang X Curr Stem Cell Res Ther; 2020; 15(7):607-613. PubMed ID: 32223738 [TBL] [Abstract][Full Text] [Related]
19. Structure of the C-terminal guanine nucleotide exchange factor module of Trio in an autoinhibited conformation reveals its oncogenic potential. Bandekar SJ; Arang N; Tully ES; Tang BA; Barton BL; Li S; Gutkind JS; Tesmer JJG Sci Signal; 2019 Feb; 12(569):. PubMed ID: 30783010 [TBL] [Abstract][Full Text] [Related]
20. ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer. Komatsu M; Ichikawa H; Chiwaki F; Sakamoto H; Komatsuzaki R; Asaumi M; Tsunoyama K; Fukagawa T; Matsushita H; Boku N; Matsusaki K; Takeshita F; Yoshida T; Sasaki H Oncogene; 2022 Oct; 41(43):4779-4794. PubMed ID: 36127398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]